Frontier Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9M | Buy |
638,204
+220,396
| +53% | +$5.84M | 0.16% | 201 |
|
|
2025
Q1 | $10.1M | Sell |
417,808
-179,931
| -30% | -$4.35M | 0.11% | 218 |
|
|
2024
Q4 | $24.1M | Buy |
597,739
+16,321
| +3% | +$657K | 0.23% | 159 |
|
|
2024
Q3 | $36.8M | Buy |
581,418
+131,221
| +29% | +$8.31M | 0.35% | 112 |
|
|
2024
Q2 | $23.9M | Buy |
450,197
+284,788
| +172% | +$15.1M | 0.24% | 155 |
|
|
2024
Q1 | $13.6M | Buy |
+165,409
| New | +$13.6M | 0.13% | 199 |
|